StockData
Ardelyx, Inc. logo

Ardelyx, Inc. (ARDX) stock

ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3058% below fair value
$3.12−0.06 (-1.89%)

Close on Nov 18, 2026Market cap $777.46MP/E –Yield –

Ardelyx operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Ardelyx's operating income for the twelve months ending Jun 30, 2026 was -$35.45M. For fiscal 2025 it was -$40.98M. The highest annual figure on record is -$1.56M in fiscal 2014.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$40.98M–
FY2024Dec 31, 2024-$27.95M–
FY2023Dec 31, 2023-$63.28M–
FY2022Dec 31, 2022-$63.76M–
FY2021Dec 31, 2021-$154.35M–
FY2020Dec 31, 2020-$90.78M–
FY2019Dec 31, 2019-$91.26M–
FY2018Dec 31, 2018-$90.95M–
FY2017Dec 31, 2017-$65.12M–
FY2016Dec 31, 2016-$112.90M–
FY2015Dec 31, 2015-$29.39M–
FY2014Dec 31, 2014-$1.56M–
FY2013Dec 31, 2013-$2.87M–
FY2012Dec 31, 2012-$8.81M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$12.43M–
Q1 FY2026Mar 31, 2026-$32.79M–
Q4 FY2025Dec 31, 2025$5.10M-37.2%
Q3 FY2025Sep 30, 2025$4.67M+109.0%
Q2 FY2025Jun 30, 2025-$14.40M–
Q1 FY2025Mar 31, 2025-$36.35M–
Q4 FY2024Dec 31, 2024$8.13M–
Q3 FY2024Sep 30, 2024$2.23M-69.8%
Q2 FY2024Jun 30, 2024-$13.63M–
Q1 FY2024Mar 31, 2024-$24.68M–
Q4 FY2023Dec 31, 2023-$27.99M-330.5%
Q3 FY2023Sep 30, 2023$7.40M–
Q2 FY2023Jun 30, 2023-$16.62M–
Q1 FY2023Mar 31, 2023-$26.06M–
Q4 FY2022Dec 31, 2022$12.14M–
Q3 FY2022Sep 30, 2022-$21.88M–
Q2 FY2022Jun 30, 2022-$26.22M–
Q1 FY2022Mar 31, 2022-$27.81M–
Q4 FY2021Dec 31, 2021-$35.27M–
Q3 FY2021Sep 30, 2021-$42.24M–
Q2 FY2021Jun 30, 2021-$44.83M–
Q1 FY2021Mar 31, 2021-$32.01M–
Q4 FY2020Dec 31, 2020-$27.64M–
Q3 FY2020Sep 30, 2020-$17.16M–
Q2 FY2020Jun 30, 2020-$24.21M–
Q1 FY2020Mar 31, 2020-$21.77M–
Q4 FY2019Dec 31, 2019-$18.85M–
Q3 FY2019Sep 30, 2019-$22.09M–
Q2 FY2019Jun 30, 2019-$24.83M–
Q1 FY2019Mar 31, 2019-$25.50M–
Q4 FY2018Dec 31, 2018-$27.38M-349.7%
Q3 FY2018Sep 30, 2018-$23.73M–
Q2 FY2018Jun 30, 2018-$22.15M–
Q1 FY2018Mar 31, 2018-$17.69M–
Q4 FY2017Dec 31, 2017$10.96M–
Q3 FY2017Sep 30, 2017-$21.23M–
Q2 FY2017Jun 30, 2017-$26.42M–
Q1 FY2017Mar 31, 2017-$28.43M–
Q4 FY2016Dec 31, 2016-$31.48M–
Q3 FY2016Sep 30, 2016-$29.20M–

More Ardelyx figures

See a number that looks wrong?